Silence Therapeutics (SLN)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

539.00p
   
  • Change Today:
      9.00p
  • 52 Week High: 649.00
  • 52 Week Low: 339.00
  • Currency: UK Pounds
  • Shares Issued: 89.74m
  • Volume: 1,020
  • Market Cap: £483.67m
  • RiskGrade: 177

Regulatory News

Holding(s) in Company 08-Sep-2021 16:03 RNS
Holding(s) in Company 08-Sep-2021 16:00 RNS
Silence Appoints Senior VP of BD, AM and NPD. 01-Sep-2021 07:00 RNS
Silence to Participate in Investor Conferences 25-Aug-2021 07:00 RNS
Silence Therapeutics Report Half-Year 2021 Results 12-Aug-2021 07:00 RNS
Holding(s) in Company 06-Aug-2021 12:15 RNS
Holding(s) in Company 06-Aug-2021 12:13 RNS
Total Voting Rights 05-Aug-2021 14:57 RNS
Notice of half year results 15-Jul-2021 07:00 RNS
Results of Annual General Meeting 15-Jun-2021 17:54 RNS
Silence to present SL124 data at EHA 07-Jun-2021 07:00 RNS
$40m Payment from AstraZeneca for Collaboration 25-May-2021 07:00 RNS
Phase 1 Study in Healthy Volunteers Positive Data 19-May-2021 07:00 RNS
Silence attends RBC Global Healthcare Conference 12-May-2021 07:00 RNS
Notice of AGM 07-May-2021 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

SLN Market Data

Currency UK Pounds
Share Price 539.00p
Change Today 9.00p
% Change 1.70 %
52 Week High 649.00
52 Week Low 339.00
Volume 1,020
Shares Issued 89.74m
Market Cap £483.67m
RiskGrade 177

SLN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.31% below the market average43.31% below the market average43.31% below the market average43.31% below the market average43.31% below the market average
48% below the sector average48% below the sector average48% below the sector average48% below the sector average48% below the sector average
Price Trend
15.37% above the market average15.37% above the market average15.37% above the market average15.37% above the market average15.37% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average
Income Not Available
Growth
25.80% above the market average25.80% above the market average25.80% above the market average25.80% above the market average25.80% above the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SLN Dividends

No dividends found

Trades for 23-Sep-2021

Time Volume / Share Price
15:11 602 @ 534.10p
15:00 33 @ 534.16p
14:42 5 @ 539.00p
12:54 9 @ 548.63p
12:04 10 @ 548.63p

Top of Page